Fortis Healthcare Limited (BOM:532843)
India flag India · Delayed Price · Currency is INR
944.80
-3.65 (-0.38%)
At close: Jul 31, 2026

Fortis Healthcare Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
10,4187,7425,9895,8875,551
Depreciation & Amortization
4,3953,7463,3213,0532,854
Other Amortization
99.02109.96103.88103.88154.92
Loss (Gain) From Sale of Assets
-17.63-269.91-98.3-169.08-116.12
Asset Writedown & Restructuring Costs
-393.78---
Loss (Gain) From Sale of Investments
-349.91740.87-92.71-743.5-3,061
Loss (Gain) on Equity Investments
-163.52-115.23-95.1-218.39-241.47
Provision & Write-off of Bad Debts
595.38618.05396.21463.32382.1
Other Operating Activities
3,0132,3861,28989.53,242
Change in Accounts Receivable
-2,807-2,199-878.83-1,233-846.39
Change in Inventory
-157.03-86.41138.92-19.96-382.21
Change in Accounts Payable
1,1351,044519.411,0421,383
Change in Other Net Operating Assets
-145.41138.05417.08-33.65-256.72
Operating Cash Flow
16,01414,23911,0018,2228,654
Operating Cash Flow Growth
12.47%29.44%33.79%-4.99%78.25%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-9,455-8,469-9,425-4,472-2,155
Sale of Property, Plant & Equipment
171.66400.972,767222.861,002
Cash Acquisitions
-8,698-278.64-1,150-263.83-3,250
Investment in Securities
2,148-43.28-1,396492.66-1,127
Other Investing Activities
449.72596.54340.47283.66380.91
Investing Cash Flow
-15,384-7,794-8,864-3,737-5,144

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-3.96---
Long-Term Debt Issued
12,71015,6096,1192,4013,064
Total Debt Issued
12,71015,6136,1192,4013,064
Short-Term Debt Repaid
-6.66--38.58-860.99-444.91
Long-Term Debt Repaid
-7,258-2,505-4,785-4,796-6,322
Total Debt Repaid
-7,264-2,505-4,823-5,657-6,767
Net Debt Issued (Repaid)
5,44513,1081,296-3,256-3,703
Common Dividends Paid
-776.64-1,089-860.32-159.77-
Other Financing Activities
-3,031-19,158-1,300-1,297-1,470
Financing Cash Flow
1,638-7,139-864.58-4,712-5,173

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
12.6-4.56-27.5212.420.55
Miscellaneous Cash Flow Adjustments
3.46---0.22137.15
Net Cash Flow
2,284-697.581,245-214.55-1,525

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
6,5595,7701,5763,7506,499
Free Cash Flow Growth
13.68%266.04%-57.97%-42.30%143.42%
Free Cash Flow Margin
7.19%7.41%2.29%5.96%11.37%
Free Cash Flow Per Share
8.697.642.094.978.61
Levered Free Cash Flow
1,908-15,08918,7951,8555,310
Unlevered Free Cash Flow
3,598-14,18719,3802,4726,056

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
3,0311,3811,3001,2971,470
Cash Income Tax Paid
2,6991,0972,2182,7422,114
Change in Working Capital
-1,975-1,104196.58-244.04-102.27